✦ LIBER ✦

Metformin + saxagliptin for type 2 diabetes

✍ Scribed by Scheen, André J

Book ID: 118201053
Publisher: Informa plc
Year: 2011
Tongue: English
Weight: 231 KB
Volume: 13
Category: Article
ISSN: 1465-6566
DOI: 10.1517/14656566.2012.642867

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Saxagliptin Add-on Therapy to Insulin Wi

Saxagliptin Add-on Therapy to Insulin With or Without Metformin for Type 2 Diabetes Mellitus: 52-Week Safety and Efficacy

✍ Barnett, Anthony H.; Charbonnel, Bernard; Li, Jia; Donovan, Mark; Fleming, Dougl 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 449 KB

Saxagliptin is non-inferior to glipizide

Saxagliptin is non-inferior to glipizide in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: a 52-week randomised controlled trial

✍ B. Göke; B. Gallwitz; J. Eriksson; Å. Hellqvist; I. Gause-Nilsson; for the D1680 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB

Cost-effectiveness and budget impact of

Cost-effectiveness and budget impact of saxagliptine as additional therapy to metformin for the treatment of diabetes mellitus type 2 in the Brazilian private health system

✍ Nita, Marcelo Eidi; Eliaschewitz, Freddy G.; Ribeiro, Eliane; Asano, Elio; Barbo 📂 Article 📅 2012 🏛 Elsevier ⚖ 107 KB

Saxagliptin shows promise for type 2 dia

Saxagliptin shows promise for type 2 diabetes

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

Metformin suitable for paediatric type 2

Metformin suitable for paediatric type 2 diabetes

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB

Saxagliptin (Onglyza): new DPP-4 inhibit

Saxagliptin (Onglyza): new DPP-4 inhibitor for type 2 diabetes

✍ Steve Chaplin; Jiten Vora 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 85 KB